Lifecore Biomedical, Inc. \de\: Form 10-KT, filed Mar 16, 2026
Filed with the SEC on Mar 16, 2026 and accepted by EDGAR at Mar 16, 2026, 08:15 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cash and equivalents | At period end2025-12-31 | $17.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $82.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $232.2m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $23.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $198.1m | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $142.2m | us-gaap:LongTermDebt |
| Current portion of debt | At period end2025-12-31 | $954.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-12-31 | −$14.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001005286-26-000009. Last ingested by Listed: Oct 30, 2026, 17:35 ET. Listed shows no prices and gives no investment advice.